These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30337031)

  • 1. Inflammatory Bowel Disease: What Very Early Onset Disease Teaches Us.
    Crowley E; Muise A
    Gastroenterol Clin North Am; 2018 Dec; 47(4):755-772. PubMed ID: 30337031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the optimum strategy for identifying adults and children with coeliac disease: systematic review and economic modelling.
    Elwenspoek MM; Thom H; Sheppard AL; Keeney E; O'Donnell R; Jackson J; Roadevin C; Dawson S; Lane D; Stubbs J; Everitt H; Watson JC; Hay AD; Gillett P; Robins G; Jones HE; Mallett S; Whiting PF
    Health Technol Assess; 2022 Oct; 26(44):1-310. PubMed ID: 36321689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Very early onset IBD: novel genetic aetiologies.
    Batura V; Muise AM
    Curr Opin Allergy Clin Immunol; 2018 Dec; 18(6):470-480. PubMed ID: 30299396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse switching from the biosimilar SB2 to the originator infliximab in previously switched patients with inflammatory bowel diseases: results of a prospective long-term cohort study.
    Fischer S; Donhauser M; Cohnen S; Fietkau K; Vetter M; Grübel-Liehr M; Dietrich P; Rath T; Wilfer A; Sologub L; Krebs S; Dörje F; Nagore D; Meyer S; Neurath MF; Atreya R
    Therap Adv Gastroenterol; 2024; 17():17562848241301887. PubMed ID: 39619829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies used for childhood chronic functional constipation: the SUCCESS evidence synthesis.
    Todhunter-Brown A; Booth L; Campbell P; Cheer B; Cowie J; Elders A; Hagen S; Jankulak K; Mason H; Millington C; Ogden M; Paterson C; Richardson D; Smith D; Sutcliffe J; Thomson K; Torrens C; McClurg D
    Health Technol Assess; 2024 Jan; 28(5):1-266. PubMed ID: 38343084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal microbiota is associated with extraintestinal manifestations in inflammatory bowel disease.
    Hertz S; Anderson JM; Nielsen HL; Schachtschneider C; McCauley KE; Özçam M; Larsen L; Lynch SV; Nielsen H
    Ann Med; 2024 Dec; 56(1):2338244. PubMed ID: 38648495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. INFLAMMATORY BOWEL DISEASE AND ASSOCIATED SKIN MANIFESTATIONS.
    Ghani U; Ahmed M; Nayeem A; Qayyum Z
    J Ayub Med Coll Abbottabad; 2024; 36(3):616-620. PubMed ID: 39623845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In reviewing the emerging biomarkers of human inflammatory bowel disease (IBD): Endothelial progenitor cells (EPC) and their vesicles as potential biomarkers of cardiovascular manifestations and targets for personalized treatments.
    Balistreri CR
    Mech Ageing Dev; 2024 Dec; 222():112006. PubMed ID: 39577473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intestinal microbiome, but not clinical aspects of inflammatory bowel disease, is impacted by lactose malabsorption compared to lactose digestion in children.
    Cohen A; Li J; Butcher J; Singleton R; Barbeau P; Stintzi A; Mack DR
    Am J Clin Nutr; 2024 Dec; 120(6):1335-1343. PubMed ID: 39374806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical and oral steroids for otitis media with effusion (OME) in children.
    Mulvaney CA; Galbraith K; Webster KE; Rana M; Connolly R; Tudor-Green B; Marom T; Daniel M; Venekamp RP; Schilder AG; MacKeith S
    Cochrane Database Syst Rev; 2023 Dec; 12(12):CD015255. PubMed ID: 38088821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "I've Spent My Whole Life Striving to Be Normal": Internalized Stigma and Perceived Impact of Diagnosis in Autistic Adults.
    Huang Y; Trollor JN; Foley KR; Arnold SRC
    Autism Adulthood; 2023 Dec; 5(4):423-436. PubMed ID: 38116050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservative, physical and surgical interventions for managing faecal incontinence and constipation in adults with central neurological diseases.
    Todd CL; Johnson EE; Stewart F; Wallace SA; Bryant A; Woodward S; Norton C
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD002115. PubMed ID: 39470206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for maintenance of medically-induced remission in Crohn's disease.
    Gordon M; Sinopoulou V; Akobeng AK; Sarian A; Moran GW
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD012609. PubMed ID: 38372447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical fluoride as a cause of dental fluorosis in children.
    Wong MCM; Zhang R; Luo BW; Glenny AM; Worthington HV; Lo ECM
    Cochrane Database Syst Rev; 2024 Jun; 6(6):CD007693. PubMed ID: 38899538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synbiotics, prebiotics and probiotics for people with chronic kidney disease.
    Cooper TE; Khalid R; Chan S; Craig JC; Hawley CM; Howell M; Johnson DW; Jaure A; Teixeira-Pinto A; Wong G
    Cochrane Database Syst Rev; 2023 Oct; 10(10):CD013631. PubMed ID: 37870148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health Services Utilization and Specialist Care in Pediatric Inflammatory Bowel Disease: A Multiprovince Population-Based Cohort Study.
    Kuenzig ME; Bitton A; Carroll MW; Otley AR; Singh H; Kaplan GG; Stukel TA; Mack DR; Jacobson K; Griffiths AM; El-Matary W; Targownik LE; Nguyen GC; Jones JL; Murthy SK; Bernstein CN; Lix LM; Peña-Sánchez JN; Dummer TJB; Spruin S; Fung SG; Nugent Z; Coward S; Cui Y; Coulombe J; Filliter C; Benchimol EI
    Inflamm Bowel Dis; 2024 Dec; 30(12):2356-2369. PubMed ID: 38366807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel targets for mucosal healing in inflammatory bowel disease therapy.
    Mansouri P; Mansouri P; Behmard E; Najafipour S; Kouhpayeh A; Farjadfar A
    Int Immunopharmacol; 2025 Jan; 144():113544. PubMed ID: 39571265
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.